*3.3. Health Care-Related Impact of the Pandemic*

Problems with the access to a neurologist were reported by 63 (21.9%) respondents, with the access to a primary care physician or other specialist in 144 (50.2%) cases, and with access to rehabilitation in 103(35.9%). Thirty four (11.8%) subjects found relevant information about their condition hardly available. With regard to DMT, 29 (10.1%) patients reported the obstacles in continuation of scheduled treatment, 16 (5.6%)—a delay in introduction of treatment and 8 (2.8%)—a delay in planned switch to another DMT. Forty-five persons (15.7%) cancelled in- or outpatient visit because of fear of infection, and 34 of them were offered a remote consultation.
